ACE II
A system called renin - angiotensin - exists in human plasma and tissueIn human plasma (blood) in ACE Ⅱ is a powerful vasoconstrictor, the effect on blood vessels is one of the important causes of hypertension. Blood vessel walls of these local tissue ACE Ⅱ caused organ involvement in hypertension (such asHeart failure, chronic cerebral insufficiency, and chronic renal ischemic injury) play a negative roleMore significant.ACE inhibitors, also known as angiotensin-converting enzyme inhibitors, are a class of high blood resistanceIn general, ACE inhibitors lower blood pressure because they block the bodyGenerated within the ACE Ⅱ, it is generated by inhibiting ACE Ⅱ need a pushAn enzyme called angiotensin-converting enzyme (ACE) does this.
Scientists at Cambridge university found a link between the use of angiotensin-converting enzyme inhibitors (and similar drugs) and acute kidney injury. ACE inhibitors and related drugs ACE ii receptor antagonists (ARAS or "" sartan" "), the second most common prescription drug in the UK, are used primarily to treat common conditions such as high blood pressure, heart disease and kidney problems. While studies have suggested a link between the use of these drugs and kidney damage in the past, the magnitude of the link has not been known. Therefore, to explore this issue, the researchers collected the rate of admission of acute renal injury in British hospitals and the rate of use of ACE inhibitors and ARAS prescriptions. The diagnostic rate of acute kidney injury increased by 52 percent from 2007/08 to 2010/11. Over the same period, the number of ACE inhibitors and ARAS prescriptions prescribed by general practitioners increased by 16 percent. The results showed that there was a significant correlation between the increase of the number of prescriptions and the increase of hospital admission rate of acute renal injury. The researchers estimated that if the number of ACE inhibitors and ARAS prescriptions were maintained at 2007/08, there could be 1,636 cases of acute kidney damage that could be avoided. They estimated that one of the seven cases of acute kidney injury may be due to the use of these prescribed drugs.
At present, DLDEVELOP co. LTD has developed corresponding ACE II Elisa products. To get more information, you could contact our professional staff directly or directly to our website:
https://dldevelop.com/Research-reagent/dl-ace2-hu.html
Scientists at Cambridge university found a link between the use of angiotensin-converting enzyme inhibitors (and similar drugs) and acute kidney injury. ACE inhibitors and related drugs ACE ii receptor antagonists (ARAS or "" sartan" "), the second most common prescription drug in the UK, are used primarily to treat common conditions such as high blood pressure, heart disease and kidney problems. While studies have suggested a link between the use of these drugs and kidney damage in the past, the magnitude of the link has not been known. Therefore, to explore this issue, the researchers collected the rate of admission of acute renal injury in British hospitals and the rate of use of ACE inhibitors and ARAS prescriptions. The diagnostic rate of acute kidney injury increased by 52 percent from 2007/08 to 2010/11. Over the same period, the number of ACE inhibitors and ARAS prescriptions prescribed by general practitioners increased by 16 percent. The results showed that there was a significant correlation between the increase of the number of prescriptions and the increase of hospital admission rate of acute renal injury. The researchers estimated that if the number of ACE inhibitors and ARAS prescriptions were maintained at 2007/08, there could be 1,636 cases of acute kidney damage that could be avoided. They estimated that one of the seven cases of acute kidney injury may be due to the use of these prescribed drugs.
At present, DLDEVELOP co. LTD has developed corresponding ACE II Elisa products. To get more information, you could contact our professional staff directly or directly to our website:
https://dldevelop.com/Research-reagent/dl-ace2-hu.html
